ORAGENICS, INC. Other Receivables, Net, Current
ORAGENICS, INC. (OGEN) had Other Receivables, Net, Current of $35.10 thousand as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Notes › Nontrade Receivables
us-gaap:OtherReceivablesNetCurrent · last filed 2023-11-09
- 2023-09-30: Other Receivables, Net, Current $35.10K.
- 2023-06-30: Other Receivables, Net, Current $13.16K.
- 2021-12-31: Other Receivables, Net, Current $6.99K.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2023-09-30 | $35.10K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $13.16K 10-Q · filed 2023-08-11 |
| 2021-12-31 | $6.99K 10-K · filed 2023-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |